ArthroVision Accepts Court Decision, Abandons German Part Of Osteoarthritis

Chondrometrics has announced that ArthroVision, a wholly-owned subsidiary of Horizon Sciences & Technologies, has accepted the decision of the District Court of Munich, Germany. As per the court ruling, Chondrometrics does not make use of the claims of ArthroVision’s patent EP 1230561, and therefore does not infringe on the German part of the patent.

ArthroVision has withdrawn its appeal for the first instance judgment to be taken to the 2nd level of jurisdiction, and thus accepts the decision as the final one.

Montreal-based ArthroVision has also abandoned the German part of the Osteoarthritis research related European patent EP 1230561. It waived all claims against Chondrometrics based on this patent for the past, in view of an invalidity complaint filed by Chondrometrics in the German Federal Patent Court of Munich.